Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Alessandro Russo

Humanitas University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cell Biology Cell Biology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (13)

Alessandro Di Federico

University of Bologna

ITALY

View details

Paolo Borghetti

Brescia University College

ITALY

View details

Andrea Riccardo Filippi

Associate Professor

University of Milan

ITALY

View details

María Isabel Loza García

Professor of Pharmacology with tenure

Universidade de Santiago de Compostela

SPAIN

View details

Christian Rolfo

Division of Medical Oncology Director

Ohio State University

UNITED STATES

View details

David J. Pinato

Imperial College London

UNITED KINGDOM

View details

Michele Montrone

IRCCS Istituto Tumori Giovanni Paolo II

ITALY

View details

Vittorio Gebbia

ITALY

View details

Fausto Omero

University of Messina

ITALY

View details

Marco Chiappetta

Docenti di ruolo di IIa fascia

Magna Graecia University

ITALY

View details

Andrea De Giglio

University of Bologna

ITALY

View details

Bartlomiej Tomasik

Medical University of Gdansk

POLAND

View details

Diego De Miguel Pérez

Assistant professor

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessandro Russo

Research Interests

Explore related searches

Articles (20)

Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry

Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study

Game-Set-MATCH: Liquid Biopsy Advances to the Next Round

ADCs and TCE in SCLC Therapy: The Beginning of a New Era?

Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION group

Stratifying risk in oligoprogressive EGFR-mutated non-small cell lung cancer (NSCLC): The role of liquid biopsy

Could 18F-FES PET Be a New Driver in Therapeutic Choice for Metastatic HR+/HER2− Patients?

Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database

Expression of Membrane Targets for Therapeutics in RET -Positive Non-Small Cell Lung Cancer

Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL

Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer

The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer

Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers

Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC.

The Chemoimmunotherapy Revolution in Resectable NSCLC—The Times They Are A-Changin’

Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer

Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy

Collaborators (13)

Alessandro Di Federico

Paolo Borghetti

Andrea Riccardo Filippi

María Isabel Loza García

Christian Rolfo

David J. Pinato

Michele Montrone

Vittorio Gebbia

Fausto Omero

Marco Chiappetta

Andrea De Giglio

Bartlomiej Tomasik

Diego De Miguel Pérez

Make your next move.